JP2024514355A5 - - Google Patents
Info
- Publication number
- JP2024514355A5 JP2024514355A5 JP2023564507A JP2023564507A JP2024514355A5 JP 2024514355 A5 JP2024514355 A5 JP 2024514355A5 JP 2023564507 A JP2023564507 A JP 2023564507A JP 2023564507 A JP2023564507 A JP 2023564507A JP 2024514355 A5 JP2024514355 A5 JP 2024514355A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- variant
- nucleotide sequence
- construct
- sequence identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB2105684.1 | 2021-04-21 | ||
| GBGB2105684.1A GB202105684D0 (en) | 2021-04-21 | 2021-04-21 | Chimeric antigen receptor (CAR)-T cells |
| PCT/GB2022/051003 WO2022223975A1 (en) | 2021-04-21 | 2022-04-21 | Chimeric antigen receptor (car)-t cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024514355A JP2024514355A (ja) | 2024-04-01 |
| JP2024514355A5 true JP2024514355A5 (enExample) | 2025-04-25 |
Family
ID=76377669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023564507A Pending JP2024514355A (ja) | 2021-04-21 | 2022-04-21 | キメラ抗原受容体（ｃａｒ）－ｔ細胞 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240181056A1 (enExample) |
| EP (1) | EP4326759A1 (enExample) |
| JP (1) | JP2024514355A (enExample) |
| KR (1) | KR20240000541A (enExample) |
| CN (1) | CN117545765A (enExample) |
| AU (1) | AU2022260700A1 (enExample) |
| CA (1) | CA3215838A1 (enExample) |
| GB (1) | GB202105684D0 (enExample) |
| WO (1) | WO2022223975A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025527559A (ja) * | 2022-08-23 | 2025-08-22 | インペリアル・カレッジ・イノベーションズ・リミテッド | Ｔｃｒベータ鎖可変領域に対するキメラ抗原受容体（ｃａｒ） |
| CN116058334B (zh) * | 2022-11-21 | 2023-08-08 | 中国人民解放军军事科学院军事医学研究院 | 一种可视化gvhd动物模型的构建方法及其应用 |
| CN122003245A (zh) * | 2023-07-10 | 2026-05-08 | 普拉里生物科技有限公司 | 用于过继转移细胞疗法的基因工程化黏膜相关恒定t (mait)细胞 |
| WO2025208050A2 (en) * | 2024-03-28 | 2025-10-02 | The Regents Of The University Of California | Engineered mucosal-associated invariant t (mait) cells and methods of making and using thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10245262B2 (en) | 2014-04-01 | 2019-04-02 | The University Of Queensland | Immunological reagents and uses therefor |
| GB201506423D0 (en) * | 2015-04-15 | 2015-05-27 | Tc Biopharm Ltd | Gamma delta T cells and uses thereof |
| ES2851123T1 (es) * | 2014-09-26 | 2021-09-03 | Baylor College Medicine | Receptores quiméricos de antígeno específicos de glipicano-3 para inmunoterapia adoptiva |
| CA2977106A1 (en) * | 2015-02-27 | 2016-09-01 | Icell Gene Therapeutics Llc | Chimeric antigen receptors (cars) targeting hematologic malignancies, compositions and methods of use thereof |
| CN109897114B (zh) * | 2017-12-08 | 2022-08-02 | 亘喜生物科技（上海）有限公司 | 具有自杀基因开关的靶向cd47的工程化免疫细胞 |
| US20220403001A1 (en) * | 2018-06-12 | 2022-12-22 | Obsidian Therapeutics, Inc. | Pde5 derived regulatory constructs and methods of use in immunotherapy |
| CN113286875B (zh) * | 2018-12-19 | 2024-08-09 | Inserm(法国国家健康医学研究院) | 表达嵌合抗原受体的黏膜相关不变t(mait)细胞 |
| CN113840912A (zh) * | 2019-05-16 | 2021-12-24 | 南京传奇生物科技有限公司 | 包含识别分子的工程化免疫细胞 |
-
2021
- 2021-04-21 GB GBGB2105684.1A patent/GB202105684D0/en not_active Ceased
-
2022
- 2022-04-21 AU AU2022260700A patent/AU2022260700A1/en active Pending
- 2022-04-21 US US18/287,551 patent/US20240181056A1/en active Pending
- 2022-04-21 CA CA3215838A patent/CA3215838A1/en active Pending
- 2022-04-21 CN CN202280044126.1A patent/CN117545765A/zh active Pending
- 2022-04-21 EP EP22720011.0A patent/EP4326759A1/en active Pending
- 2022-04-21 KR KR1020237039737A patent/KR20240000541A/ko active Pending
- 2022-04-21 JP JP2023564507A patent/JP2024514355A/ja active Pending
- 2022-04-21 WO PCT/GB2022/051003 patent/WO2022223975A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7744479B2 (ja) | 抗ヒトパピローマウイルス１６ ｅ７ ｔ細胞受容体 | |
| JP6923714B2 (ja) | Ｍｈｃクラスｉｉ拘束性ｍａｇｅ−ａ３を認識するｔ細胞受容体 | |
| JP7223822B2 (ja) | 抗ヒトパピローマウイルス１６ ｅ６ ｔ細胞受容体 | |
| CN112300269B (zh) | Kras突变特异性t细胞受体筛选及抗肿瘤用途 | |
| JP7735373B2 (ja) | 多鎖キメラポリペプチドおよびその使用 | |
| AU2025203455A9 (en) | HLA class I-restricted T cell receptors against mutated RAS | |
| AU2017258745B2 (en) | Anti-KK-LC-1 T cell receptors | |
| JP2022109953A5 (enExample) | ||
| CN103483452B (zh) | 双信号独立的嵌合抗原受体及其用途 | |
| JP2020096630A5 (enExample) | ||
| JP2023139070A5 (enExample) | ||
| JPH07501698A (ja) | 二価特異性ヘテロ二量体 | |
| KR20200004807A (ko) | 나노의약에서 수용체-리간드 상호작용의 효능을 측정하기 위한 어세이 | |
| JP2022545362A (ja) | キメラ抗原受容体及びその使用 | |
| JP2022547967A (ja) | Ｃｄ４０細胞質ドメインを含むキメラ抗原レセプター及びその使用 | |
| CN111892661A (zh) | 一种嵌合抗原受体及其在制备治疗肿瘤的产品中的应用 | |
| CN110343166A (zh) | 识别afp抗原短肽的t细胞受体 | |
| CN114286863A (zh) | 一种双特异性嵌合抗原受体 | |
| CN111850014A (zh) | 一种细胞因子增效的嵌合抗原受体及其应用 | |
| JP2024515347A5 (enExample) | ||
| CN110016074A (zh) | Mage-a3人源化t细胞受体 | |
| CN116836260A (zh) | 一种识别mage-a4的t细胞受体及其编码序列和应用 | |
| CN117165568B (zh) | 工程化改造的psd蛋白、细胞外囊泡及其制备方法和应用 | |
| EP4538285A1 (en) | Pd-1 variant and use thereof | |
| CN118930660A (zh) | 含有膜型rgd的融合蛋白和表达该融合蛋白的免疫细胞及其应用 |